Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Tyra Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate

Author: Happy Mohamed | March 19, 2024 04:12pm
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.48) by 10.42 percent. This is a 70.97 percent decrease over losses of $(0.31) per share from the same period last year.

Posted In: TYRA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist